BR0213165A - Uso de ácido hidroxioléico e compostos relacionados na manufatura de drogas - Google Patents
Uso de ácido hidroxioléico e compostos relacionados na manufatura de drogasInfo
- Publication number
- BR0213165A BR0213165A BR0213165-0A BR0213165A BR0213165A BR 0213165 A BR0213165 A BR 0213165A BR 0213165 A BR0213165 A BR 0213165A BR 0213165 A BR0213165 A BR 0213165A
- Authority
- BR
- Brazil
- Prior art keywords
- acid
- hydroxiolic
- related compounds
- manufacture
- drug manufacture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
"USO DE áCIDO HIDROXIOLéICO E COMPOSTOS RELACIONADOS NA MANUFATURA DE DROGAS". A presente invenção refere-se a uso do ácido hidroxioléico e de seus compostos análogos na manufatura de drogas. Descreve o uso do ácido hidroxioléico e de seus análogos de fórmula geral I: COOH-CHR-(CH~ 2~)~ m~CH=CH-(CH~ 2~)~ n~-CH~ 3~, em que m e n têm, independentemente, um valor de 015 e R pode ser qualquer resíduo com peso molecular abaixo de 200 Da, na manufatura de drogas que podem ser usadas no tratamento de câncer, hipertensão, obesidade ou doenças mediadas por alteração da estrutura da membrana e a regulação conseq³ente das proteínas G ou dos receptores ligados a elas.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ESP200102269 | 2001-10-11 | ||
ES200102269A ES2186576B1 (es) | 2001-10-11 | 2001-10-11 | Acido 2-hidroxioleico para utilizar como medicamento. |
PCT/ES2002/000475 WO2003030891A1 (es) | 2001-10-11 | 2002-10-09 | Utilizacion del acido hidroxioleico y compuestos analogos del mismo en la fabricacion de medicamentos |
Publications (3)
Publication Number | Publication Date |
---|---|
BR0213165A true BR0213165A (pt) | 2004-09-14 |
BRPI0213165B1 BRPI0213165B1 (pt) | 2018-01-23 |
BRPI0213165B8 BRPI0213165B8 (pt) | 2021-05-25 |
Family
ID=8499164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0213165A BRPI0213165B8 (pt) | 2001-10-11 | 2002-10-09 | uso de ácido hidroxioléico e compostos relacionados na manufatura de drogas |
Country Status (13)
Country | Link |
---|---|
US (3) | US20050014831A1 (pt) |
EP (1) | EP1435235B1 (pt) |
JP (1) | JP4737931B2 (pt) |
CN (3) | CN100471492C (pt) |
AT (1) | ATE322261T1 (pt) |
BR (1) | BRPI0213165B8 (pt) |
CA (1) | CA2463348C (pt) |
DE (1) | DE60210488T2 (pt) |
ES (2) | ES2186576B1 (pt) |
MX (1) | MXPA04003255A (pt) |
PT (1) | PT1435235E (pt) |
RU (1) | RU2310445C2 (pt) |
WO (1) | WO2003030891A1 (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2229935B1 (es) * | 2003-10-10 | 2006-10-01 | Universitat De Les Illes Balears | Utilizacion del acido hidroxioleico y compuestos analagos del mismo como aditivos alimentarios funcionales. |
JP2009051732A (ja) * | 2005-12-13 | 2009-03-12 | Meiji Seika Kaisha Ltd | Pparリガンド活性を有する組成物 |
CN101570481B (zh) * | 2008-04-30 | 2012-02-01 | 上海医药工业研究院 | 一种多羟基长链脂肪酸及其分离提取方法和在抑制芳香化酶活性中的应用 |
ES2342997B1 (es) * | 2008-12-09 | 2011-06-06 | Universitat De Les Illes Balears | Alpha derivados de acidos grasos cis-monoinsaturados para ser usados como medicamento. |
ES2345241B1 (es) * | 2009-03-16 | 2011-09-08 | Lipopharma Therapeutics | Uso de 2-hidroxiderivados de acidos grasos poliinsaturados como medicamentos. |
WO2011089265A1 (en) | 2010-01-25 | 2011-07-28 | Bridge Bioresearch Plc | Use of fatty acid compounds for lowering blood glucose levels |
CN101985420B (zh) * | 2010-01-29 | 2014-04-30 | 苏州润新生物科技有限公司 | 油酸酯及其制备方法和在制备用于治疗高血压及其并发症的药物中的应用 |
ES2401629B1 (es) * | 2011-10-07 | 2014-03-04 | Universitat De Les Illes Balears | Enantiómeros de 2-hidroxiderivados de ácidos grasos y su uso como medicamentos. |
WO2013108428A1 (ja) * | 2012-01-19 | 2013-07-25 | 日本水産株式会社 | 食欲抑制剤 |
WO2013132092A1 (en) | 2012-03-09 | 2013-09-12 | Pensieve International Plc | Use of monounsaturated fatty acid compounds for controlling the body weight of a dog or a cat |
WO2014049071A1 (en) * | 2012-09-26 | 2014-04-03 | Tangent Reprofiling Limited | Modulators of androgen synthesis |
GB201217296D0 (en) | 2012-09-27 | 2012-11-14 | Alta Innovations Ltd | Method of treatment and/or prevention |
ES2731251T3 (es) * | 2014-10-21 | 2019-11-14 | Univ Illes Balears | Compuestos de 2-hidroxi-triacilglicerol para uso en el tratamiento de una enfermedad |
US10756968B2 (en) | 2015-01-26 | 2020-08-25 | Rapid7, Inc. | Network resource management devices methods and systems |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61297A (ja) * | 1984-06-12 | 1986-01-06 | 日本油脂株式会社 | オレイン酸の製造法 |
GB8603621D0 (en) | 1986-02-14 | 1986-03-19 | Habib N | Modifying lipid structure of cell membranes |
JPS6344843A (ja) * | 1986-08-13 | 1988-02-25 | Kao Corp | 油中水中油型乳化油脂組成物 |
CN1035925C (zh) * | 1988-11-16 | 1997-09-24 | 许正 | 亲细胞非均质分子脂质的制备方法 |
US5422371A (en) * | 1992-05-27 | 1995-06-06 | Arch Development Corp. | Methods and compositions for inhibiting 5α-reductase activity |
CN1118218A (zh) * | 1995-03-16 | 1996-03-13 | 姜训书 | 松籽油的制作方法及松籽保健食用油 |
CN1118228A (zh) * | 1995-03-16 | 1996-03-13 | 姜训书 | 松籽果酱 |
GB9506837D0 (en) * | 1995-04-03 | 1995-05-24 | Scotia Holdings Plc | Triglycerides |
PT771817E (pt) * | 1995-10-30 | 2003-06-30 | Oleoyl Estrone Developments S | Mono-esteres de oleato de estrogenos para o tratamento da obesidade e/ou excesso de peso |
US5856537A (en) * | 1996-06-26 | 1999-01-05 | The Scripps Research Institute | Inhibitors of oleamide hydrolase |
DE19727636C1 (de) * | 1997-06-28 | 1998-11-19 | Rwe Dea Ag | Verfahren zur Herstellung von 2-Alkylcarbonsäuren |
CN1212867A (zh) * | 1997-09-29 | 1999-04-07 | 宋凤亭 | 防治心脑血管疾病的组合物 |
PT948963E (pt) * | 1998-01-21 | 2003-09-30 | Fideline | Feromonas tranquilizantes para diminuir o stress a ansiedade e a agressividade dos porcos |
US6214875B1 (en) * | 1998-04-14 | 2001-04-10 | Zhenhua Yang | Anticancer effects of specific branched-chain fatty acids and related production process |
GB2389788B (en) * | 2000-12-23 | 2005-07-20 | Univ Creighton | Methods for inducing apoptosis and inhibiting proliferation in cancer cells |
DE10130491A1 (de) * | 2001-06-25 | 2003-04-17 | Heirler Horst | Verwendung von mittelkettigen Triglyceriden zur Prävention und Therapie von Adipositas |
-
2001
- 2001-10-11 ES ES200102269A patent/ES2186576B1/es not_active Expired - Fee Related
-
2002
- 2002-10-09 ES ES02783094T patent/ES2261752T3/es not_active Expired - Lifetime
- 2002-10-09 JP JP2003533923A patent/JP4737931B2/ja not_active Expired - Lifetime
- 2002-10-09 CN CNB028201132A patent/CN100471492C/zh not_active Expired - Lifetime
- 2002-10-09 CN CN2008100917937A patent/CN101259121B/zh not_active Expired - Fee Related
- 2002-10-09 BR BRPI0213165A patent/BRPI0213165B8/pt not_active IP Right Cessation
- 2002-10-09 CN CN2008100917941A patent/CN101259122B/zh not_active Expired - Fee Related
- 2002-10-09 US US10/488,726 patent/US20050014831A1/en not_active Abandoned
- 2002-10-09 AT AT02783094T patent/ATE322261T1/de active
- 2002-10-09 EP EP02783094A patent/EP1435235B1/en not_active Expired - Lifetime
- 2002-10-09 DE DE60210488T patent/DE60210488T2/de not_active Expired - Lifetime
- 2002-10-09 CA CA2463348A patent/CA2463348C/en not_active Expired - Lifetime
- 2002-10-09 RU RU2004114229/15A patent/RU2310445C2/ru active
- 2002-10-09 PT PT02783094T patent/PT1435235E/pt unknown
- 2002-10-09 WO PCT/ES2002/000475 patent/WO2003030891A1/es active IP Right Grant
- 2002-10-09 MX MXPA04003255A patent/MXPA04003255A/es active IP Right Grant
-
2008
- 2008-04-15 US US12/082,938 patent/US7851507B2/en not_active Expired - Lifetime
-
2010
- 2010-11-04 US US12/939,641 patent/US8778995B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
RU2004114229A (ru) | 2005-04-20 |
PT1435235E (pt) | 2006-08-31 |
US20110136906A1 (en) | 2011-06-09 |
CN1688302A (zh) | 2005-10-26 |
CA2463348C (en) | 2011-04-05 |
US8778995B2 (en) | 2014-07-15 |
EP1435235B1 (en) | 2006-04-05 |
ES2186576A1 (es) | 2003-05-01 |
RU2310445C2 (ru) | 2007-11-20 |
DE60210488T2 (de) | 2006-12-14 |
BRPI0213165B8 (pt) | 2021-05-25 |
EP1435235A1 (en) | 2004-07-07 |
DE60210488D1 (de) | 2006-05-18 |
US7851507B2 (en) | 2010-12-14 |
CN100471492C (zh) | 2009-03-25 |
CA2463348A1 (en) | 2003-04-17 |
CN101259122B (zh) | 2011-04-06 |
CN101259122A (zh) | 2008-09-10 |
MXPA04003255A (es) | 2005-01-25 |
JP4737931B2 (ja) | 2011-08-03 |
ES2261752T3 (es) | 2006-11-16 |
US20090082446A1 (en) | 2009-03-26 |
CN101259121A (zh) | 2008-09-10 |
ES2186576B1 (es) | 2004-09-16 |
ATE322261T1 (de) | 2006-04-15 |
BRPI0213165B1 (pt) | 2018-01-23 |
CN101259121B (zh) | 2011-04-06 |
WO2003030891A1 (es) | 2003-04-17 |
JP2005527479A (ja) | 2005-09-15 |
US20050014831A1 (en) | 2005-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0213165A (pt) | Uso de ácido hidroxioléico e compostos relacionados na manufatura de drogas | |
RU2325389C2 (ru) | Композиция и производные замещенного азаиндолоксоацетапиперазина, обладающие противовирусной активностью | |
DE502005010170D1 (de) | Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel | |
CR8659A (es) | Antagonistas del receptor de pgd2 para el tratamiento de enfermedades inflamatorias | |
BR0211502A (pt) | Derivados de ácido acético de indano e seu uso como agentes farmacêuticos, intermediários, e método de preparação | |
CA2481723A1 (en) | 5ht2c receptor modulators | |
BR0209685A (pt) | Derivado de um peptìdeo insulinotrópico e sais farmaceuticamente aceitáveis produzidos a partir do mesmo, método de produção de derivado de peptìdeo insulinotrópico e uso de um derivado de peptìdeo insulinotrópico e de sais farmaceuticamente aceitáveis | |
DK1003504T3 (da) | Indolderivater og deres anvendelse som PCP-1-antagonister | |
DE60205564D1 (de) | N-Adamantylalkyl Benzamide Derivativen als p2x7-rezeptor antagonisten | |
ATE496622T1 (de) | Verwendung von thienopyridonderivaten als ampk- aktivatoren und pharmazeutische zusammensetzungen,die diese enthalten | |
ATE478685T1 (de) | Prodrugs mit neuen biospaltbaren verbindern | |
CY1110952T1 (el) | Παραγωγα κινουκλιδινης και η χρηση αυτων ως μουσκαρινικοι ανταγωνιστες υποδοχεων μ3 | |
SE0302760D0 (sv) | New compounds | |
HK1098460A1 (en) | Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders | |
ATE442865T1 (de) | Dreigeteilte konjugate mit einer struktur, die mit zellmembran-rafts interagieren und ihre verwendung | |
CY1114803T1 (el) | Παραγωγα πυριμιδινο σουλφοναμιδιου ως ρυθμιστες υποδοχεων χημειοκινης | |
NO20021448L (no) | Nye tiazolo-(4,5-D)pyrimidinforbindelser | |
EP2202222A3 (en) | Indene derivatives, their preparation and use as medicaments | |
EA200500054A1 (ru) | Новые соединения, применимые для лечения ожирения, сахарного диабета ii типа и расстройств центральной нервной системы | |
EA200501595A1 (ru) | Азабициклические производные в качестве антагонистов мускаринового рецептора | |
WO2007010552A3 (en) | N- terminal peg conjugate of erythropoietin | |
ATE524478T1 (de) | Substituierte spiro-verbindungen und deren verwendung zur herstellung von arzneimitteln gegen schmerz | |
CY1114479T1 (el) | Φαρμακολογικη επικουρικη αγωγη σε συνδυασμο με διηθητικη χειρουργικη επεμβαση γλαυκωματος | |
BRPI0415020A (pt) | dissulfeto, sulfeto, sulfóxido e derivados de sulfona de açúcares cìclicos e usos dos mesmos | |
BRPI0413013A (pt) | composto, seus sais, solvatos, e derivados farmaceuticamente funcionais, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou distúrbios, e de doenças |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] | ||
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/10/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 09/10/2022 |